Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$16.71

0.31 (1.89%)

07:06
05/07/19
05/07
07:06
05/07/19
07:06

Coherus Biosciences initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao started Coherus Biosciences with a Buy rating and $28 price target. A fast launch for first product Udenyca, a biosimilar to Amgen's Neulasta, bodes well for long-term value creation, Tsao tells investors in a research note.

  • 09

    May

  • 22

    May

CHRS Coherus Biosciences
$16.71

0.31 (1.89%)

05/14/18
MAXM
05/14/18
NO CHANGE
Target $22
MAXM
Buy
Coherus Biosciences price target raised to $22 from $18 at Maxim
Maxim analyst Jason McCarthy raised his price target on Coherus Biosciences to $22 from $18 after the company announced that the FDA has accepted for review the recently re-submitted BLA for CHS-1701, a biosimilar version of Neulasta. The BSUFA date for a decision is November 3, he noted. The analyst keeps his Buy rating on Coherus Biosciences shares.
06/05/18
MSCO
06/05/18
NO CHANGE
Target $50
MSCO
Overweight
Neulasta biosimilar could 'reignite' Mylan momentum, says Morgan Stanley
Morgan Stanley analyst David Risinger said FDA approval of Fulphila, Mylan's (MYL) biosimilar to Amgen's (AMGN) Neulasta, should be a "substantial and durable" profit opportunity and could "reignite" Mylan's upward momentum. He notes that Mylan anticipates launching Fulphila in the coming weeks and that the FDA biosimilar user fee act action date for Coherus' (CHRS) Neulasta biosimilar is November 3. Risinger has an Overweight rating and $50 price target on Mylan shares.
07/27/18
SBSH
07/27/18
NO CHANGE
Target $25
SBSH
Buy
Citi sees Coherus trading to $21-$25 on today's EMA decision
The European Medicines Agency this morning provided a positive opinion on Coherus Biosciences' version of Neulasta, Citi analyst Mohit Bansal tells investors in a research note. This is positive news as it "significantly lowers" regulatory risk for Neulasta in the U.S. as well, Bansal tells investors in a research note. He notes that while the applicant name is not Coherus on the two applications receiving positive opinions today, the drug name trademark "Udenyca" is registered under Coherus and it seems a third party filed the application on Coherus' behalf. The analyst sees the stock trading in the $21-$25 range on the news. He keeps a Buy rating on Coherus Biosciences with a $25 price target. The stock in premarket trading is up 8%, or $1.40, to $19.75.
08/28/18
HCWC
08/28/18
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert started Coherus Biosciences (CHRS) with a Buy rating and $28 price target. The analyst expects approval of the company's Udencya in both the U.S. and Europe this year. His confidence level is driven by a positive recommendation from the European Committee for Medicinal Products for Human Use in July for marketing authorization of Udencya, a biosimilar compound targeting febrile neutropenia. Coherus announced that the committee reviewed all the new immunogenicity data that were required for the U.S. re-submission too, so the EU recommendation for approval adds a measure of confidence in support of U.S. approval, Kolbert tells investors in a research note. A year-end approval should position Udencya as the second biosimilar in the $4B U.S. marketplace behind Mylan (MYL), which should be launching its product following approval in June, the analyst adds.

TODAY'S FREE FLY STORIES

UAL

United Continental

$93.88

-0.12 (-0.13%)

10:46
07/17/19
07/17
10:46
07/17/19
10:46
Hot Stocks
United Continental CEO says China business was volatile due to trade issues »

Comments provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SLB

Schlumberger

$39.13

-0.95 (-2.37%)

10:45
07/17/19
07/17
10:45
07/17/19
10:45
Options
Schlumberger call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

PNC

PNC Financial

$140.14

1.48 (1.07%)

10:44
07/17/19
07/17
10:44
07/17/19
10:44
Hot Stocks
Breaking Hot Stocks news story on PNC Financial »

PNC Financial says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

INO

Inovio

$2.60

-0.405 (-13.50%)

10:43
07/17/19
07/17
10:43
07/17/19
10:43
Recommendations
Inovio analyst commentary  »

Inovio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PNC

PNC Financial

$140.35

1.69 (1.22%)

10:43
07/17/19
07/17
10:43
07/17/19
10:43
Hot Stocks
Breaking Hot Stocks news story on PNC Financial »

PNC Financial says on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

DOYU

DouYu

$0.00

(0.00%)

10:42
07/17/19
07/17
10:42
07/17/19
10:42
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

10:40
07/17/19
07/17
10:40
07/17/19
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

EBAY

eBay

$39.72

-0.18 (-0.45%)

, GOOG

Alphabet

$1,151.72

-1.25 (-0.11%)

10:38
07/17/19
07/17
10:38
07/17/19
10:38
Earnings
Fly Intel: What to watch in eBay earnings report »

eBay (EBAY) is scheduled…

EBAY

eBay

$39.72

-0.18 (-0.45%)

GOOG

Alphabet

$1,151.72

-1.25 (-0.11%)

GOOGL

Alphabet Class A

$1,151.74

-1.12 (-0.10%)

PYPL

PayPal

$119.63

-0.05 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

PNC

PNC Financial

$139.92

1.26 (0.91%)

10:35
07/17/19
07/17
10:35
07/17/19
10:35
Hot Stocks
PNC Financial notes 'uncertainty' in economy, outlook for rates »

Comments taken from Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

HLF

Herbalife Nutrition

$40.00

-1.87 (-4.47%)

10:35
07/17/19
07/17
10:35
07/17/19
10:35
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

DOYU

DouYu

$0.00

(0.00%)

10:31
07/17/19
07/17
10:31
07/17/19
10:31
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

10:30
07/17/19
07/17
10:30
07/17/19
10:30
General news
Crude inventories for week of July 12 »

Crude oil inventories…

FXI

iShares China Large-Cap ETF

$42.28

0.09 (0.21%)

10:20
07/17/19
07/17
10:20
07/17/19
10:20
Options
Short-term put buyer in China ETF bought delta neutral »

Short-term put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/17/19
07/17
10:17
07/17/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

, OPRA

Opera

$11.00

0.41 (3.87%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

OPRA

Opera

$11.00

0.41 (3.87%)

WORK

Slack Technologies

$34.19

-0.24 (-0.70%)

JLL

Jones Lang LaSalle

$140.23

-0.06 (-0.04%)

ALSN

Allison Transmission

$47.46

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

HSY

Hershey

$144.07

3.64 (2.59%)

, COP

ConocoPhillips

$60.31

0.57 (0.95%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

HSY

Hershey

$144.07

3.64 (2.59%)

COP

ConocoPhillips

$60.31

0.57 (0.95%)

CTRP

Ctrip

$38.35

1.48 (4.01%)

KBH

KB Home

$26.58

-0.16 (-0.60%)

SLGN

Silgan Holdings

$30.47

0.09 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

MFGP

Micro Focus

$21.23

0.57 (2.76%)

, WFC

Wells Fargo

$45.45

0.15 (0.33%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MFGP

Micro Focus

$21.23

0.57 (2.76%)

WFC

Wells Fargo

$45.45

0.15 (0.33%)

ARLP

Alliance Resource Partners

$16.87

-0.38 (-2.20%)

WUBA

58.com

$57.07

-0.68 (-1.18%)

RL

Ralph Lauren

$111.09

-4.07 (-3.53%)

LEVI

Levi Strauss

$18.76

-1.05 (-5.30%)

PVH

PVH Corp.

$89.89

-2.61 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

  • 12

    Oct

  • 15

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOYU

DouYu

$0.00

(0.00%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

LEVI

Levi Strauss

$18.74

-1.07 (-5.40%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Options
Levi Strauss put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Fed funds futures have a light bid »

Fed funds futures have a…

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Breaking General news story  »

Week of 7/12 EIA…

DOYU

DouYu

$0.00

(0.00%)

10:13
07/17/19
07/17
10:13
07/17/19
10:13
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:09
07/17/19
07/17
10:09
07/17/19
10:09
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:05
07/17/19
07/17
10:05
07/17/19
10:05
Syndicate
DouYu indicated to open at $12.00, IPO priced at $11.50 »

DouYu (DOYU) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.